PTGS2 and pancreatic neoplasm: Cyclooxygenase-2 (COX-2) inhibitor NS398 suppresses CEMIP expression in colorectal adenomas [153], decreases CEMIP expression, and hinders migration in pancreatic cancer cells [91].